NFKB1 and neoplasm: Finally, the Myd88L252P tumor gene expression profile not only highlights the canonical NF-κB p65/RelA activation pathway and proliferation, but also strikingly shares an Xbp1 centered lymphoplasmacytic B-cell differentiation signature with MYD88L265P WM.